Defiance Daily Target 2X Long MRNA ETF(MRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNX Defiance Daily Target 2X Long MRNA ETF

盘前交易 04-27 07:01:11 EDT

25.57

-2.28

-8.17%

最高26.83	最低25.57	成交量1,999
今开26.23	昨收27.85	日振幅4.51%
总市值76.71万	流通市值76.71万	总股本3.00万
成交额5.29万	换手率6.66%	流通股本3.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":25.5703,"timestamp":1777060800000,"preClose":27.8458,"halted":0,"volume":1999,"delay":0,"changeRate":-0.08171788923284663,"floatShares":30000,"shares":30000,"eps":0,"marketStatus":"盘前交易","change":-2.2755,"latestTime":"04-27 07:01:11 EDT","open":26.23,"high":26.8252,"low":25.5703,"amount":52854.7021,"amplitude":0.045066,"askPrice":36.73,"askSize":1,"bidPrice":18.18,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777296600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":25.5703,"sharesOutstanding":30000,"nav":27.8,"aum":834000,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.5703,"preClose":25.5703,"latestTime":"19:32 EDT","volume":110,"amount":2812.24,"timestamp":1777073563805,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.18788418892358671},"requestUrl":"/m/hq/s/MRNX","defaultTab":"news","newsList":[{"id":"1146538586","title":"Moderna获欧盟批准上市Mcombriax——全球首款mRNA流感与新冠联合疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1146538586","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146538586?lang=zh_cn&edition=full","pubTime":"2026-04-21 21:46","pubTimestamp":1776779188,"startTime":"0","endTime":"0","summary":"生物技术巨头Moderna, Inc.宣布，其研发的mRNA联合疫苗Mcombriax已正式获得欧盟委员会的市场营销授权。该疫苗是全球首个采用mRNA技术同时针对流感和COVID-19的联合疫苗，标志着传染病预防领域取得重大突破。\n此次授权为欧盟成员国接种Mcombriax铺平道路，有望简化疫苗接种流程，提升公共卫生防护效率。Moderna的创新疫苗技术平台再次展现其应对复杂病毒威胁的潜力。\n业界分析指出，此次获批将强化Moderna在欧洲疫苗市场的竞争地位，并为其他多价疫苗研发提供重要参考。随着秋冬呼吸道疾病高发季临近，联合疫苗的市场需求预计将持续增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4568","MRNY","BK4551","MRNX","BK4501","BK4533","BK4588","BK4139","BK4532","BK4548","MRNA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618973837","title":"莫德纳盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618973837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618973837?lang=zh_cn&edition=full","pubTime":"2026-03-11 23:09","pubTimestamp":1773241765,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日23时09分，莫德纳股票出现波动，股价快速上涨5.04%。截至发稿，该股报57.75美元/股，成交量250.671万股，换手率0.63%，振幅5.35%。莫德纳股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Acurx Pharmaceuticals, Inc.、天演药业、Ocugen, Inc.涨幅较大，Acurx Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.、Quince Therapeutics, Inc.较为活跃，换手率分别为1506.86%、1019.35%、62.59%，振幅较大的相关个股有Acurx Pharmaceuticals, Inc.、Kala Bio, Inc.、天演药业，振幅分别为58.62%、50.19%、41.98%。截至 2025 年 8 月，莫德纳有 35 种 mRNA 开发候选药物处于临床研究中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603112309259548dd23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603112309259548dd23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNX","BK4568","BK4501","BK4139","BK4533","BK4588","BK4551","MRNY","BK4585","BK4532","BK4548","MRNA","BK4534"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1199935387","title":"Moderna将于2026年7月8日前向Arbutus/Genevant支付9.5亿美元无条件一次性款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1199935387","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199935387?lang=zh_cn&edition=full","pubTime":"2026-03-05 19:10","pubTimestamp":1772709057,"startTime":"0","endTime":"0","summary":"生物技术巨头Moderna, Inc.宣布，其已承诺在2026年7月8日或之前，向合作方Arbutus Biopharma及其子公司Genevant Sciences支付一笔总额高达9.5亿美元的无条件一次性款项。此次支付不附带任何后续条件，标志着双方在相关技术平台合作上的一个重要财务里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4585","BK4588","BK4501","BK4568","BK4533","BK4139","MRNA","MRNX","BK4551","BK4534","BK4548","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144697251","title":"ETF日报｜三倍做多半导体ETF涨近6%；纳指三倍做多ETF涨超4%；加密与半导体产品相对跑赢","url":"https://stock-news.laohu8.com/highlight/detail?id=1144697251","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144697251?lang=zh_cn&edition=full","pubTime":"2026-03-05 09:12","pubTimestamp":1772673133,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5$2倍做多GEMI ETF-Leverage Shares$上涨65.93%。该产品两倍做多Galaxy Digital，因公司股价上涨，杠杆效应放大当日涨幅。大盘指数ETF涨幅Top 5$纳指三倍做多ETF$上涨4.49%。$三倍做多MSCI新兴市场ETF-Direxion$上涨2.92%。该产品三倍做多美国小盘股指数，指数当日上行使杠杆产品录得涨幅。该产品三倍做多半导体板块，芯片股集体走强推动杠杆产品上行。该产品配置不动产优先股，相关资产价格上行推动产品上涨。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d8aa0ef7daa8f62604f5dfb5c1b0be1b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4596","AGQ","EWP","BK4600","BK4595","LU1861558580.USD","BK4588","SOXL","TNA","USO","FAS","GLGG","BK4585","ASTS","BK4535","LU1861220207.SGD","CONI","UGL","XLY","BK4516","GLXY","SMST","ICVT","IREZ","MRNA","NBIZ","SMH","EDC","BK4112","NBIS","PXIU","UCO","GLXU","BK4551","PFFR","BK4550","LU1861559042.SGD","MSTR","IYZ","COIN","CWB","SRLN","UPXI","BKLN","IREN","DGP","LU1861217088.USD","QLD","BK4554","TQQQ","LU2360107671.USD","MRNX","BK4539","GEMG","GEMI","ASTN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616559787","title":"莫德纳(MRNA)股价上涨14%，创2024年11月以来盘中新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2616559787","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616559787?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:44","pubTimestamp":1772635499,"startTime":"0","endTime":"0","summary":"莫德纳(MRNA)股价上涨14%，创2024年11月以来盘中新高","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603043662053278.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603043662053278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4568","MRNA","BK4501","BK4533","MRNY","MRNX","BK4534","BK4548","BK4532","BK4139","BK4551","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616559337","title":"莫德纳盘初股价上涨近14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616559337","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616559337?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:39","pubTimestamp":1772635171,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","BK4588","MRNY","BK4534","BK4532","BK4501","BK4568","BK4139","BK4533","BK4548","MRNX","BK4551","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132841899","title":"Moderna股价盘前飙升3.7% 公司同意支付高达22.5亿美元和解新冠疫苗专利纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=1132841899","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132841899?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:10","pubTimestamp":1772615446,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 股价在盘前交易中强势上涨3.7%，此前该公司宣布已达成协议，将支付最高22.5亿美元，以了结与其新冠疫苗相关的专利纠纷。这一重大和解协议消除了笼罩在该公司头顶的一大不确定性，为市场注入了积极情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8a24082c651a012a7802d63b3e7455d1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","BK4139","MRNA","BK4568","BK4534","BK4532","BK4533","BK4588","BK4548","BK4501","BK4551","MRNX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616306583","title":"专利纠纷靴子即将落地 mRNA领军者Moderna(MRNA.US)转身冲向“AI+医疗”浪潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2616306583","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616306583?lang=zh_cn&edition=full","pubTime":"2026-03-04 08:46","pubTimestamp":1772585185,"startTime":"0","endTime":"0","summary":"Moderna将在第三季度支付9.5亿美元，且未来无需再支付任何专利使用费。对于Moderna增长前景而言，如果彻底摆脱专利诉讼，进而无需再支付任何专利使用费，意味着该公司有望将增长重点与研发管道全面转向“AI+医疗”超级大浪潮。Moderna 将成为“AI+医疗”浪潮的下一个爆发标的?Moderna非常有机会把“AI+医疗”真正做成核心估值引擎，尤其是在个体化肿瘤疫苗和平台化 mRNA 药物开发上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4532","BK4139","MRNA","BK4501","BK4551","BK4588","BK4548","MRNY","BK4568","BK4585","BK4534","MRNX","159891","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143945821","title":"Moderna预计2026年第一季度将因和解支付计入9.5亿美元费用","url":"https://stock-news.laohu8.com/highlight/detail?id=1143945821","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143945821?lang=zh_cn&edition=full","pubTime":"2026-03-04 05:19","pubTimestamp":1772572752,"startTime":"0","endTime":"0","summary":"生物技术巨头Moderna近日披露，公司预计在2026年第一季度财务报表中确认一笔高达9.5亿美元的费用。这笔巨额支出与一项重大和解协议的支付义务直接相关，反映出公司在法律及商业纠纷解决方面面临的财务影响。该费用的确认将遵循美国通用会计准则（GAAP）的要求，并对当期利润产生显著影响。分析人士指出，此次预提费用虽可能短期压制股价，但彻底解决历史遗留问题有助于Moderna更专注于mRNA技术管线的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","MRNX","BK4568","BK4551","BK4588","BK4139","BK4534","BK4548","MRNA","BK4532","BK4501","BK4533","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140512903","title":"Moderna最新预测：2026年末现金及现金等价物预计达45-50亿美元区间","url":"https://stock-news.laohu8.com/highlight/detail?id=1140512903","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140512903?lang=zh_cn&edition=full","pubTime":"2026-03-04 05:19","pubTimestamp":1772572752,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 最新更新了其财务展望，宣布将2026年末的现金及现金等价物预期调整至45亿至50亿美元的范围。这一修正后的预测反映了公司对其未来现金流状况的重新评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","MRNA","BK4551","BK4533","BK4534","BK4532","BK4548","MRNX","BK4501","MRNY","BK4139","BK4568","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613730353","title":"Piper Sandler上调莫德纳目标价至69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613730353","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613730353?lang=zh_cn&edition=full","pubTime":"2026-02-23 14:40","pubTimestamp":1771828834,"startTime":"0","endTime":"0","summary":"格隆汇2月23日｜Piper Sandler将莫德纳目标价从63美元上调至69美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223144112a7151e48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223144112a7151e48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNX","BK4568","BK4501","BK4139","BK4533","BK4588","BK4551","MRNY","BK4585","BK4532","BK4548","MRNA","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612287922","title":"BioNTech控告Moderna侵犯新冠疫苗专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2612287922","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612287922?lang=zh_cn&edition=full","pubTime":"2026-02-20 03:26","pubTimestamp":1771529160,"startTime":"0","endTime":"0","summary":"德国生物制药公司BioNTech周四在特拉华州联邦法院起诉Moderna，指控Moderna的新冠疫苗 mNEXSPIKE侵犯了BioNTech和辉瑞公司的竞争性疫苗Comirnaty的相关专利。　　该诉讼称，Moderna公司于2025年获得美国食品药品管理局批准的下一代新冠疫苗mNEXSPIKE，侵犯了BioNTech公司在用于简化mRNA疫苗设计的技术方面的权利，该技术允许以较低剂量为患者接种。　　Moderna在2022年起诉BioNTech及其合作伙伴辉瑞公司侵犯了Comirnaty的专利权，目前诉讼仍在进行中。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-20/doc-inhnkyhw6558658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BNTX","MRNX","MRNA","MRNY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1102127485","title":"异动解读 | FDA立场转变改善流感疫苗监管前景，Moderna盘中大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102127485","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102127485?lang=zh_cn&edition=full","pubTime":"2026-02-20 02:59","pubTimestamp":1771527578,"startTime":"0","endTime":"0","summary":"Moderna, Inc.  今日盘中股价大幅上涨5.06%，引起了市场的广泛关注。消息面上，美国食品和药物管理局改变了方针，将审查Moderna新型流感疫苗mRNA-1010的修订申请。此前一周，FDA曾拒绝了该疫苗的申请，引发了市场担忧，而此次立场的迅速反转显著改善了该疫苗的监管前景。多家券商随即更新了观点，其中William Blair将Moderna流感疫苗获得监管成功的概率从10%大幅提高到55%。RBC Capital Markets认为，FDA的迅速反转符合当前政策模式。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","MRNA","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179667827","title":"异动解读 | FDA同意审查流感疫苗，Moderna盘前大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179667827","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179667827?lang=zh_cn&edition=full","pubTime":"2026-02-18 20:39","pubTimestamp":1771418340,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 今日盘前股价大幅上涨5.28%，引起了市场的广泛关注。消息面上，美国食品和药物管理局（FDA）已同意对Moderna公司的季节性流感疫苗mRNA-1010进行审查。此前，FDA曾以试验设计存在缺陷为由拒绝了审查申请，而此次公司提交了修改后的方案，寻求全面批准该疫苗用于50至64岁人群，并加速批准用于65岁及以上人群，同时承诺在上市后进行额外的研究。这一监管进展被视为公司产品管线推进的重要一步。如果获得批准，该疫苗最早可能在2026/27年流感季节上市，为Moderna带来新的增长动力。欧洲、加拿大和澳大利亚的监管机构也在同步审查该候选疫苗。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8e8e39a7beb148acde163c9bfa12c7e1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","MRNA","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612946448","title":"Moderna(MRNA.US)：美国食品药品监督管理局将启动对其在研季节性流感疫苗申报的审查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2612946448","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612946448?lang=zh_cn&edition=full","pubTime":"2026-02-18 20:04","pubTimestamp":1771416243,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8e8e39a7beb148acde163c9bfa12c7e1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4532","BK4534","BK4551","MRNY","MRNA","BK4568","BK4501","BK4139","BK4548","BK4533","BK4588","MRNX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167501095","title":"异动解读 | Moderna盘中大涨7.97%，四季度营收超预期及疫苗进展提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1167501095","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167501095?lang=zh_cn&edition=full","pubTime":"2026-02-13 22:48","pubTimestamp":1770994100,"startTime":"0","endTime":"0","summary":"Moderna, Inc.  今日盘中股价大幅上涨7.97%，引起了市场的广泛关注。消息面上，Moderna公布的2025年第四季度财务业绩表现强劲，营收达到6.78亿美元，超出了市场分析师平均预期的6.261亿美元，这主要得益于其新冠疫苗在美国的销售好于预期。同时，公司重申了2026年营收同比增长10%的业绩指引，并预期美国市场与国际市场将各贡献约50%的营收，展现了均衡的全球化布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"85bbc709c54701e4fb883d94fb5a7407","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","MRNY","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136221151","title":"Moderna高管透露：公司期待年内获欧洲批准流感与新冠联合疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1136221151","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136221151?lang=zh_cn&edition=full","pubTime":"2026-02-13 21:38","pubTimestamp":1770989892,"startTime":"0","endTime":"0","summary":"Moderna公司高管在电话会议中表示，公司正积极争取其流感与新冠联合疫苗在今年内获得欧洲监管机构的批准。\n这一表态凸显了Moderna在推进组合疫苗商业化进程中的关键步伐，若顺利获批，将有望为欧洲地区提供更高效的呼吸道疾病防护方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4551","BK4548","MRNA","BK4568","BK4139","BK4585","BK4534","BK4588","MRNY","MRNX","BK4532","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142377976","title":"Moderna四季度营收6.78亿美元好于预期，重申年度增速指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1142377976","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142377976?lang=zh_cn&edition=full","pubTime":"2026-02-13 20:17","pubTimestamp":1770985052,"startTime":"0","endTime":"0","summary":"公司正在开发更新的产品。","market":"us","thumbnail":"https://static.tigerbbs.com/2f3840dad459cd6d96e214702ddd10d3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/2f3840dad459cd6d96e214702ddd10d3"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"85bbc709c54701e4fb883d94fb5a7407","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Moderna四季度营收6.78亿美元好于预期，重申年度增速指引","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","MRNX","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149918830","title":"Moderna预期2026年营收分布：美国与国际市场各占半壁江山","url":"https://stock-news.laohu8.com/highlight/detail?id=1149918830","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149918830?lang=zh_cn&edition=full","pubTime":"2026-02-13 20:03","pubTimestamp":1770984217,"startTime":"0","endTime":"0","summary":"Moderna公司最新预测显示，其2026年的全球营收结构将呈现均衡态势——预计美国本土市场与国际市场的贡献比例将分别达到约50%。这一战略展望凸显了该生物技术巨头在巩固北美业务的同时，正加速推进全球化布局的步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","BK4139","MRNA","BK4568","BK4534","BK4532","BK4533","BK4588","BK4548","BK4501","BK4551","MRNX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1128},{"period":"1month","weight":-0.1321},{"period":"3month","weight":0.2407},{"period":"ytd","weight":0.2407}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"ARCA","name":"Defiance Daily Target 2X Long MRNA ETF","nameEN":"Defiance Daily Target 2X Long MRNA ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Defiance Daily Target 2X Long MRNA ETF(MRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Defiance Daily Target 2X Long MRNA ETF(MRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Defiance Daily Target 2X Long MRNA ETF,MRNX,Defiance Daily Target 2X Long MRNA ETF股票,Defiance Daily Target 2X Long MRNA ETF股票老虎,Defiance Daily Target 2X Long MRNA ETF股票老虎国际,Defiance Daily Target 2X Long MRNA ETF行情,Defiance Daily Target 2X Long MRNA ETF股票行情,Defiance Daily Target 2X Long MRNA ETF股价,Defiance Daily Target 2X Long MRNA ETF股市,Defiance Daily Target 2X Long MRNA ETF股票价格,Defiance Daily Target 2X Long MRNA ETF股票交易,Defiance Daily Target 2X Long MRNA ETF股票购买,Defiance Daily Target 2X Long MRNA ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Defiance Daily Target 2X Long MRNA ETF(MRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Defiance Daily Target 2X Long MRNA ETF(MRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}